Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 17.876% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CCOc1ccc(C2=Nn3c(nnc3-c3ccccc3OC)SC2)cc1
b. CC(C)Oc1c(Br)cc(Br)cc1/C=N/NC(N)=S
c. c1ccc(CCNc2ncnc3scc(C4COc5ccccc5O4)c23)cc1
d. CCCc1cc(=O)oc2c(CN3CCOCC3)c(O)ccc12
Answer: c. c1ccc(CCNc2ncnc3scc(C4COc5ccccc5O4)c23)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
c1ccc(CCNc2ncnc3scc(C4COc5ccccc5O4)c23)cc1
c1ccc(CCNc2ncnc3scc(C4COc5ccccc5O4)c23)cc1
5-(2,3-dihydro-1,4-benzodioxin-3-yl)-N-(2-phenylethyl)thieno[2,3-d]pyrimidin-4-amine